Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sysmex Reports Net Income Of JPY4.6 Billion For Nine Months Of Fiscal 2009
During the first nine months of the fiscal year ending March 31, 2009 (April 1 to December 31, 2008), the Japanese economy experienced a further deceleration in its
During the first nine months of the fiscal year ending March 31, 2009 (April 1 to December 31, 2008), the Japanese economy experienced a further deceleration in its
The SonoDrugs collaboration aims to develop new materials and drug nanocarrier systems for improved localized drug delivery that can be activated by ultrasound waves. Magnetic resonance imaging (MRI)
Nuvo is in the process of finalizing its resubmission for Pennsaid approval, which it expects to file with the FDA within the next 60 days. Upon acceptance of
The Beneficial study, which was a Phase II double-blind, placebo-controlled, randomized trial of alagebrium in patients with chronic systolic heart failure; the Break study, which was a Phase
Under the terms of the merger transaction, Nuvelo issued approximately 4.87 million new shares of common stock to shareholders of pre-merger Arca. As a result, former Arca pre-merger
According to the company, the Taxus Liberte is the only second-generation drug-eluting stent approved for use in Japan. Design improvements over the company’s first-generation Taxus Express2 stent include
Cannasat has received a no objection letter from Health Canada to conduct this clinical study for this product that is designed to help manage neuropathic pain and other
Progression-free survival (PFS) was a prospectively defined secondary endpoint in the study. The Extend clinical trial is a Phase III single-agent trial of pixantrone for patients with relapsed,
This change in leadership is part of the restructuring process initiated by the company under the guidance of the board of directors to better prepare the company for
A patented, broad-spectrum liquid chemical warfare (CW) agent decontaminant, RSDL neutralizes or removes CW agents and T2 toxin from skin on contact, leaving a non-toxic residue that can